Nano-medicines that include nanoparticles, nanocomposites, small molecules, and
exosomes represent new viable sources for future therapies for the dysfunction of …

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …

The leading cause of death in the world, cardiovascular disease (CVD), remains a
formidable condition for researchers, clinicians and patients alike. CVD comprises a broad …

Cardiovascular diseases (CVDs) are a primary cause of death globally. A few classic and
hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness …

Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

Nanomedicine approaches have revolutionized the treatment of cancer and vascular
diseases, where the limitations of rapid nonspecific clearance, poor biodistribution and …

Nanotheranostics aims to utilize nanomaterials to prevent, diagnose, and treat diseases to
improve the quality of patients' lives. Blood vessels are responsible to deliver nutrients and …

A large majority of cardiovascular nanomedicine research has focused on fabricating
designer nanoparticles for improved targeting as a means to overcome biological barriers …

Theranostics, literally derived from the combination of the words diagnostics and therapy, is
an emerging field of clinical and preclinical research, where contrast agents, drugs and …

Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced
therapy and diagnostics. This convergent discipline merges research areas such as …